X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARVIND REMEDIES Share Price   (AREM)

Here is the latest stock price and chart of ARVIND REMEDIES. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jun 13, 2016 (Close)
Price (Rs)4.70 Open (Rs) 4.70 High (Rs) 4.70 Low (Rs) 4.70
% Change-4.86 Volume 2,850 Value (Rs) 13,395 52-Week H/L 21.49 / 3.78
Live NSE Quotes Sep 24, 2015 3:29:59 PM
Price (Rs)12.60 Open (Rs) 12.70 High (Rs) 12.95 Low (Rs) 12.40
% Change0.00 Volume 195,005 Value (Rs) 2,460,963 52-Week H/L 51.70 / 9.90
  BSE Sensex | CNX Nifty

Charts
ARVIND REMEDIES Share Price Chart (Rs) - 1 Year
Loading...
 
     
PERIOD
Advanced Charts new


Today's Market

Share Markets in India Open Flat; ONGC Top Gainer(09:30 am)

Asian stock markets are lower today against the backdrop of rising tensions on the Korean Peninsula. The Shanghai Composite is off 0.08% while the Hang Seng is down 0.01%.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Gold Imports Surge: Are People Hedging the Risk of Another Demonetisation?(Vivek Kaul's Diary)

Sep 19, 2017

Imports of the yellow metal have surged big time this year.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

A Little-Known Japanese Secret for Compounding Wealth

Sep 22, 2017

What Warren Buffett and Benjamin Graham have in common with a little known Japanese secret.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ARVIND REMEDIES

  • Track your investment in ARVIND REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS